Advisory Committee Sides With FDA: King/Acura's Acurox Fails To Prevent Abuse
This article was originally published in The Pink Sheet Daily
Executive SummaryThe public forum did no favors for Acurox, as advisory committee members questioned whether adding niacin to oxycodone would really deter abuse.
You may also be interested in...
But Purdue and Teva disagree on the key question of whether a generic of a tamper-resistant analgesic must have the same dosage form as the reference-listed brand-name drug.